| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 4.310 | 9.174 | 9.016 | 6.981 | 6.770 |
| Total Income - EUR | - | - | - | 0 | 0 | 4.310 | 9.174 | 9.016 | 6.981 | 6.770 |
| Total Expenses - EUR | - | - | - | 703 | 1.975 | 7.009 | 6.969 | 6.085 | 6.705 | 7.711 |
| Gross Profit/Loss - EUR | - | - | - | -703 | -1.975 | -2.699 | 2.204 | 2.931 | 276 | -941 |
| Net Profit/Loss - EUR | - | - | - | -703 | -1.975 | -2.755 | 2.013 | 2.660 | 90 | -941 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Avrig - Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 1.272 | 2.603 | 2.646 | 1.260 | 139 | 0 | 16.497 |
| Current Assets | - | - | - | 378 | 820 | 2.394 | 4.825 | 4.973 | 2.480 | 3.192 |
| Inventories | - | - | - | 0 | 0 | 243 | 101 | 172 | 0 | 0 |
| Receivables | - | - | - | 322 | 0 | 1.038 | 3.321 | 3.930 | 137 | 137 |
| Cash | - | - | - | 55 | 820 | 1.114 | 1.402 | 871 | 2.343 | 3.056 |
| Shareholders Funds | - | - | - | -832 | -2.790 | -5.492 | -3.358 | -708 | -616 | -1.554 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 2.482 | 7.418 | 10.631 | 9.442 | 5.820 | 3.103 | 21.482 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Avrig - Med Srl